Clinical development plan: curcumin.
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003474:Curcumin / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007972:Leukoplakia, Oral / Q000517:prevention & control*; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000517:prevention & control; D009375:Neoplasms, Glandular and Epithelial / Q000517:prevention & control*; D051381:Rats; D012107:Research Design; D018675:Toxicity Tests
D016588:Anticarcinogenic Agents; D003474:Curcumin